CD8A and angioimmunoblastic T-cell lymphoma: In a study evaluating the correlation between gene signatures and clinical outcomes in AITL, the B‐cell signature was associated with favorable outcomes, whereas the cytotoxic signature of CD8+ T cells was associated with poorer outcomes.29